Rivastigmine en
Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer’s type and dementia due to Parkinson's disease. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting. The drug is eliminated through the urine, and appears to have relatively few drug-drug interactions. Wikipedia [ - ]
Freebase Commons Metaweb System Types /type
- -
- Rivastigmine
- /wikipedia/en/Rivastigmine
- /wikipedia/en/Exelon_$0028drug$0029
- /wikipedia/en/Rivastigmine_tartrate
- /en/rivastigmine
- /user/avh/ellerdale/0085-4f9e
- /wikipedia/en/ATC_code_N06DA03
- /wikipedia/en/ATCvet_code_QN06DA03
- /wikipedia/it_id/1896662
- /wikipedia/es/Rivastigmina
- /wikipedia/it/Rivastigmina
- /wikipedia/ru_id/1613993
- /wikipedia/fr/Rivastigmine
- /wikipedia/ru/$0420$0438$0432$0430$0441$0442$0438$0433$043C$0438$043D
- /wikipedia/es_id/703446
- /wikipedia/fr_id/3630270
- /wikipedia/de_id/1076236
- /wikipedia/de/Rivastigmin
- /authority/un/who/atc/N06DA03
- /wikipedia/en_id/30864303
- /wikipedia/it_title/Rivastigmina
- /wikipedia/ru_title/$0420$0438$0432$0430$0441$0442$0438$0433$043C$0438$043D
- /wikipedia/es_title/Rivastigmina
- /wikipedia/de_title/Rivastigmin
- /wikipedia/fr_title/Rivastigmine
- /wikipedia/en_title/Rivastigmine
- /authority/drugbank/APRD00321
- /authority/acs/cas/123441-03-2
- /authority/ncbi/pubchem/compound/77991
- /base/medicaldrugs/fda_load/drug_PKI06M3IW0
- /base/medicaldrugs/fda_load/drug_formulation_ingredient_PKI06M3IW0
- /authority/us/gov/hhs/fda/srs-unii/PKI06M3IW0
- /wikipedia/it/Exelon
- /wikipedia/hu/Rivastigmin
- /wikipedia/sv_id/915833
- /wikipedia/it/Prometax
- /wikipedia/fr/123441-03-2
- /wikipedia/fa_id/796083
- /wikipedia/hu_id/37421
- /wikipedia/nl_id/1662888
- /wikipedia/hu/Rivasztigmin
- /wikipedia/pl/Riwastygmina
- /wikipedia/ja_title/$30EA$30D0$30B9$30C1$30B0$30DF$30F3
- /wikipedia/ja/$30EA$30D0$30B9$30C1$30B0$30DF$30F3
- /wikipedia/fi_title/Rivastigmiini
- /wikipedia/sv_title/Rivastigmin
- /wikipedia/pl_title/Rywastygmina
- /wikipedia/nl/Rivastigmine
- /wikipedia/fi/Exelon
- /wikipedia/ja_id/2453720
- /wikipedia/pl_id/1844794
- /wikipedia/de/Exelon_$0028Arzneistoff$0029
- /wikipedia/fr/C14H22N2O2
- /wikipedia/fa/$0631$064A$0648$0627$0633$062A$064A$06AF$0645$064A$0646
- /wikipedia/hu/Rivastigmine
- /wikipedia/fi/Rivastigmiini
- /wikipedia/es/Exelon
- /wikipedia/sv/Rivastigmin
- /wikipedia/fr/Hydrog$00E9notartrate_de_rivastigmine
- /wikipedia/fi_id/950905
- /wikipedia/hu/Exelon
- /wikipedia/ru/$042D$043A$0441$0435$043B$043E$043D
- /wikipedia/hu_title/Rivasztigmin
- /wikipedia/nl_title/Rivastigmine
- /wikipedia/fa_title/$0631$06CC$0648$0627$0633$062A$06CC$06AF$0645$06CC$0646
- /wikipedia/fa/$0631$06CC$0648$0627$0633$062A$06CC$06AF$0645$06CC$0646
- /wikipedia/pl/Rywastygmina
- -
- -
- -
- http://it.wikipedia.org/wiki/index.html?curid=1896662
- http://ru.wikipedia.org/wiki/index.html?curid=1613993
- http://es.wikipedia.org/wiki/index.html?curid=703446
- http://fr.wikipedia.org/wiki/index.html?curid=3630270
- http://de.wikipedia.org/wiki/index.html?curid=1076236
- http://en.wikipedia.org/wiki/index.html?curid=30864303
- http://it.wikipedia.org/wiki/Rivastigmina
- http://ru.wikipedia.org/wiki/Ривастигмин
- http://es.wikipedia.org/wiki/Rivastigmina
- http://de.wikipedia.org/wiki/Rivastigmin
- -
- -
- -
- -
|
- -
- -
- Rivastigmine 0.192 extended release patch
- Rivastigmine 0.192 extended release patch
- Rivastigmine 0.396 extended release patch
- Rivastigmine tartrate 3 capsule
- Rivastigmine 0.396 extended release patch
- Rivastigmine tartrate 4.5 capsule
- Rivastigmine tartrate 1.5 capsule
- Rivastigmine tartrate 6 capsule
- Rivastigmine tartrate 2 solution
- -
User Domain Tag It /base/tagit
User Domain Schema staging /base/schemastaging
| IPA | Yomigana | Pinyin | Zhuyin | Text | Value of property |
|---|---|---|---|---|---|
|
|||||
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
| Variant name | Preferred in regions |
|---|---|
|
|
- Exelon
- -
- -